(E)-5-(4-((3-hydroxypropyl)(methyl)amino)-2-methoxybenzylidene)-1-methyl-3-phenyl-2-thioxoimidazolidin-4-one

ID: ALA5287582

Max Phase: Preclinical

Molecular Formula: C22H25N3O3S

Molecular Weight: 411.53

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1cc(N(C)CCCO)ccc1/C=C1\C(=O)N(c2ccccc2)C(=S)N1C

Standard InChI:  InChI=1S/C22H25N3O3S/c1-23(12-7-13-26)18-11-10-16(20(15-18)28-3)14-19-21(27)25(22(29)24(19)2)17-8-5-4-6-9-17/h4-6,8-11,14-15,26H,7,12-13H2,1-3H3/b19-14+

Standard InChI Key:  UUFRGRCHCSZSNP-XMHGGMMESA-N

Molfile:  

 
     RDKit          2D

 29 31  0  0  0  0  0  0  0  0999 V2000
   -0.9677    0.6933    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2531    1.1056    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4586    0.6937    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4586   -0.1314    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2513   -0.5432    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9677   -0.1351    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6824   -0.5477    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6824   -1.3729    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3969   -0.1351    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1733    1.1063    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8879    0.6937    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6025    1.1063    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.2213    0.5349    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8906   -0.1995    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.0663   -0.1072    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.6025    1.9315    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4827   -0.6907    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.0184    0.7485    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    3.3031   -0.9141    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1284   -0.9141    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5409   -1.6288    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1283   -2.3434    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3031   -2.3434    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8906   -1.6288    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1116   -0.5477    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.8263   -0.1351    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.5409   -0.5477    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2531    1.9308    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9678    2.3434    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  2  0
  3  2  1  0
  4  3  2  0
  5  4  1  0
  1  6  1  0
  6  5  2  0
  6  7  1  0
  7  8  1  0
  7  9  1  0
  3 10  1  0
 10 11  2  0
 12 11  1  0
 12 13  1  0
 13 14  1  0
 15 14  1  0
 11 15  1  0
 12 16  1  0
 15 17  2  0
 13 18  2  0
 19 14  1  0
 19 20  1  0
 21 20  2  0
 22 21  1  0
 23 22  2  0
 19 24  2  0
 24 23  1  0
  9 25  1  0
 25 26  1  0
 26 27  1  0
  2 28  1  0
 28 29  1  0
M  END

Alternative Forms

  1. Parent:

    ALA5287582

    ---

Associated Targets(Human)

NOX4 Tchem NADPH oxidase 4 (333 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYBB Tchem Cytochrome b-245 heavy chain (193 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 411.53Molecular Weight (Monoisotopic): 411.1617AlogP: 3.12#Rotatable Bonds: 7
Polar Surface Area: 56.25Molecular Species: NEUTRALHBA: 5HBD: 1
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 3.91CX LogP: 2.99CX LogD: 2.99
Aromatic Rings: 2Heavy Atoms: 29QED Weighted: 0.56Np Likeness Score: -1.11

References

1. Shim S, Jeong DU, Kim H, Kim CY, Park H, Jin Y, Kim KM, Lee HJ, Kim DH, Bae YS, Choi Y..  (2022)  Discovery of a NADPH oxidase inhibitor, (E)-3-cyclohexyl-5-(4-((2-hydroxyethyl)(methyl)amino)benzylidene)-1-methyl-2-thioxoimidazolidin-4-oneone, as a novel therapeutic for Parkinson's disease.,  244  [PMID:36274279] [10.1016/j.ejmech.2022.114854]

Source